piracetam in chronic ischemic heart disease

Experience using piracetam in patients with chronic ischemic heart disease

Shubina TI, Zaitsev VP.

Klin Med (Mosk) 1989 May;67(5):36-8


Course piracetam treatment was conducted in 34 IHD patients with neurotic and neurotic-like diseases. Dynamic changes in the psychic state were assessed by the clinical scale and the MMPI psychological test. Significant improvement or normalization of the psychic state was achieved in 58.8% of the patients treated with piracetam. The best results were obtained in the treatment of asthenic states. Administration of piracetam had no influence on the incidence of angina pectoris attacks and produced no side effects.